KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?

Background: KRAS G12D mutation subtype is present in over 40% of pancreatic ductal adenocarcinoma (PDAC), one of the leading global causes of cancer death. This retrospective cohort study aims to investigate whether detection of the KRAS G12D mutation subtype in PDAC patients is a determinant of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Henry, Lundy, Joanne, Strickland, Andrew H., Harris, Marion, Swan, Michael, Desmond, Christopher, Jenkins, Brendan J., Croagh, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562007/
https://www.ncbi.nlm.nih.gov/pubmed/36231137
http://dx.doi.org/10.3390/cells11193175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562007/
https://www.ncbi.nlm.nih.gov/pubmed/36231137
http://dx.doi.org/10.3390/cells11193175

Ejemplares similares